Tyra Bioscience, Inc TYRA 深 沪
等待开盘 05-22 09:30:00 美东时间
33.305
-0.095
-0.28%
华盛通- 最 高33.50
- 今 开32.99
- 成交量 28.23万股
- 最 低 32.56
- 昨 收 33.40
- 总市值 19.81亿
- 52周最高 40.65
- 市盈率 静 --
- 换手率 0.47%
- 52周最低 8.98
- 委 比 -96.56%
- 总股本 5947.04万
- 历史最高 40.65
- 量 比 0.54
- 振 幅 2.81%
- 历史最低 4.93
- 每 手 1
- 风险率 10.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wolfe Research Initiates Coverage On Tyra Biosciences with Peer Perform Rating
Wolfe Research analyst Kalpit Patel initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Peer Perform rating.
05-19 20:13
美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $45 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $45 price target.
05-14 18:31
Tyra Biosciences Q1 EPS $(0.64) Misses $(0.59) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 36.17 percent decrease over losses of $(0.47) per share from
05-13 20:09
美股大行评级 | 大行互评！花旗银行、贝莱德获多家大行上调目标价；哈里伯顿、强生、Patterson获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Knightscope"买入"评级，目标价从25美元升至26美元；杰富瑞：维持Allogene疗法"买入"评级，目标价从6美元升至10美元
04-16 10:14
Guggenheim Initiates Coverage On Tyra Biosciences with Buy Rating, Announces Price Target of $54
Guggenheim analyst Brad Canino initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $54.
04-15 20:21
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级； 大摩上调希捷科技目标价从468美元升至582美元
今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元
04-07 11:53
Canaccord Genuity Initiates Coverage On Tyra Biosciences with Buy Rating, Announces Price Target of $50
Canaccord Genuity analyst John Newman initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $50.
04-06 20:49
美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Piper Sandler Maintains Overweight on Tyra Biosciences, Raises Price Target to $56
Piper Sandler analyst Allison Bratzel maintains Tyra Biosciences (NASDAQ:TYRA) with a Overweight and raises the price target from $42 to $56.
03-20 23:35
